ArticleFrontiers in nutrition2026
Anti-inflammatory dietary interventions in inflammatory bowel disease: current insights and future perspectives.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), arises from multifactorial interactions involving genetics, gut microbiota dysbiosis, immune dysregulation, and environmental triggers, with diet playing a pivotal role. Anti-inflammatory dietary patterns have emerged as adjunctive therapies to pharmacological treatments, potentially inducing and maintaining remission by modulating microbiota and inflammation. This perspective reviews the mechanistic basis for dietary interventions, evaluates key strategies such as the Mediterranean diet (MD), Specific Carbohydrate Diet (SCD), low-FODMAP diet, IBD-Anti-Inflammatory Diet (IBD-AID), and Groningen Anti-Inflammatory Diet (GrAID), and discusses clinical evidence, challenges, and implications. While promising, evidence is constrained by heterogeneous studies and small cohorts. Future research should prioritize large-scale randomized controlled trials (RCTs) with multi-omics integration for personalized nutrition in IBD management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.